Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Wanbury Limited
WANBURY | NSE
230.42
INR8.47
3.82%
WANBURY | NSE
Loading StockChartView...
About Wanbury Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
01/04/2026
Close
230.42
Open
232.87
High
233.04
Low
225.00
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology orthopedics heamatinics anti-diabetic nutraceuticals gastro intestinal stroke surgery antibiotics cough and cold solutions anti-inflammatory analgesics and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic anti-analgesic anti-depressant anti-histaminic anti-inflammatory anti-arthritis anti-thrombotic anti-epileptic and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai India.
View LessWANBURY | NSE
Risk
47.5
Sharpe
-0.18
Luna's Score
39/100
Recommendation
Sell
Luna says (WANBURY | NSE)
What's Working
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
What's not Working
Price Below SMA10D
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
54.7%1 month
47.5%3 months
73.0%6 months
57.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
15.72
Fwd. PE
-
Price to book
29.32
Debt to equity
4.17
Debt to assets
0.34
Ent. to EBITDA
9.51
Ent. to rev.
1.63
PEG
-
Other Fundamentals
EBITDA
683.94M
MarketCap
7.54B
MarketCap(USD)
80.97M
Div. yield
-
Op. margin
5.86
Erngs. growth
-78.30
Rev. growth
-10.40
Ret. on equity
51.37
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
42.05
Range1M
47.40
Range3M
122.50
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.70
Price X volume
16.00M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 9.51 | 24.85 | Cheaper |
| Ent. to Revenue | 1.63 | 11.40 | Cheaper |
| PE Ratio | 15.72 | 51.36 | Cheaper |
| Price to Book | 29.32 | 6.83 | Expensive |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 72.99 | 42.17 | Riskier |
| Debt to Equity | 4.17 | 0.35 | Expensive |
| Debt to Assets | 0.34 | 0.17 | Expensive |
| Market Cap | 7.54B | 290.82B | Emerging |
